NexGen Medical Systems, Inc. Raising $10 Million to Launch Blood Clot Removal System for DVT
Published: Jul 31, 2012
Industry: Medical devices (surgery)
Location: Reno, Nevada, and Melbourne, Florida
Solution/Product: The company’s current focus is commercializing a catheter-based product line for removal of blood clots in vessels in the head and neck of patients with deep vein thrombosis and stroke. The drug warfarin, which is often given to DVT patients, can cause blood clots to fragment and migrate to the lungs, heart or brain, CEO John Kucharczyk said. NexGen’s thrombectomy product line, used under X-ray guidance, is intended to encapsulate the blood clot and remove it without the use of any drugs.